CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported fourth-quarter net income of $45.7 million.

On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of 47 cents.

The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.

The biopharmaceutical company posted revenue of $396.8 million in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $382.1 million.

For the year, the company reported a loss of $536 million, or $5.80 per share. Revenue was reported as $1.24 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News